Transplant International : Proceedings of the 7th Congress of the European Society for Organ Transplantation Vienna, October 3–7, 1995

Front Matter....Pages I-XV
Front Matter....Pages 1-1
Short-term outcome of kidney transplants from non-heart-beating donors after preservation by machine perfusion....Pages 76-80
Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients....Pages 32-33
Acute rejection relapses posttransplant: definition of risk group and evaluation of potent therapeutic regimens....Pages 34-37
Steroid-resistant rejection in kidney-transplanted patients: is ATG treatment for three or ten days preferable?....Pages 38-40
Randomized trial of misoprostol in patients with chronic renal transplant rejection....Pages 41-44
Increased tenascin expression is an early feature of the development of transplant renal arteriopathy in humans....Pages 45-48
Is kidney transplantation in sensitized recipients justified?....Pages 49-53
Low-density lipoprotein oxidation is increased in kidney transplant recipients....Pages 54-57
The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection....Pages 58-62
A critical analysis of soluble interleukin-2 receptor levels in kidney allograft recipients....Pages 63-67
Diagnostic value of urinary enzyme determination in renal transplantation....Pages 68-72
Rat cytomegalovirus infection and chronic kidney allograft rejection....Pages 3-4
Does delayed kidney graft function increase the risk of chronic rejection?....Pages 5-7
Evaluation of the permissible mismatch concept....Pages 8-10
The significant effect of HLA-DRB1 matching on acute rejection in kidney transplants....Pages 11-15
Five-year results of renal transplantation in highly sensitized recipients....Pages 16-19
Anticipation of highly sensitised renal patients’ immunoadsorption requirements by prescreening using protein A minicolumns....Pages 20-24
Weak expression of blood type B antigen in kidney tissue and successful B-incompatible kidney transplantation without special treatments....Pages 25-27
Retroperitoneal placement of living related adult renal grafts in children less than 5 years of age — a feasible technique?....Pages 73-75
Outcome of renal graft recipients with hepatitis C virus infection....Pages 28-31
Front Matter....Pages 1-1
Transplantation of kidneys harvested from non-heart-beating donors: early and long-term results....Pages 81-83
Effective surface cooling of the kidney during vascular anastomosis decreases the risk of delayed kidney function after transplantation....Pages 84-85
Kidney transplantation to patients with congenital malformations of the distal urinary tract....Pages 86-89
Front Matter....Pages 91-91
Two-year data from the European multicentre tacrolimus (FK 506) liver study....Pages 144-150
Tumor recurrence after oLTX....Pages 151-154
The importance of late infections for the long-term outcome after liver transplantation....Pages 155-156
Hepatic resuscitation after warm anoxia: one approach for increasing the donor pool for liver transplantation....Pages 120-125
Cytokine pattern in patients with infections after liver transplantation....Pages 126-131
Prediction of graft dysfunction by analysis of liver biopsies after cold storage....Pages 132-134
Validation of endothelin (ET) immunoreactivity in human bile by HPLC. Comparison of biliary ET concentration in liver transplant recipients with values obtained during cholecystectomy....Pages 135-139
First clinical realization of continuous monitoring of liver microcirculation after transplantation by thermodiffusion....Pages 140-143
Impact of enalapril on microvascular perfusion and leukocyte adherence in a model of rat liver transplantation assessed by in vivo microscopy....Pages 93-96
Quantitative analysis of the microcirculation of xenogeneic haemoperfused rat livers by intravital microscopy....Pages 97-99
Beneficial effects of prostaglandin E 1 on hemodynamic changes during liver transplantation in pigs....Pages 100-104
Pharmacokinetics of intravenous adriamycin for anhepatic chemotherapy during liver transplantation....Pages 105-108
Living related liver transplantation in children with hypoxemia related to intrapulmonary shunting....Pages 157-159
Growth and height in children after liver transplantation....Pages 160-163
Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival....Pages 109-111
DNA flow cytometry in patients undergoing liver transplantation for hepatocellular carcinoma....Pages 112-114
Clinical significance of recurrent primary biliary cirrhosis after liver transplantation....Pages 115-119
Front Matter....Pages 91-91
Indications for Tacrolimus anti-rejection therapy in liver allograft recipients....Pages 164-170
Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation....Pages 171-173
Extension of the indication for living related liver transplantation from children to adults based on resolution of graft size mismatch in relation to tissue oxygenation and metabolic load: a case report....Pages 174-177
Incidence and outcome of arterial complications after orthotopic liver transplantation....Pages 178-181
Hepato-venous outflow complications following orthotopic liver transplantation with various techniques for hepato-venous reconstruction in adults and children....Pages 182-184
Bile duct splintage in liver transplantation: is it necessary?....Pages 185-187
Effect of pre-reperfusion portal venous blood flush on early liver transplant function....Pages 188-190
How to estimate the size of the donor liver....Pages 191-194
Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection?....Pages 195-197
Hepatitis C: Indication for anti-viral therapy?....Pages 198-201
Effectiveness of early α-interferon therapy for hepatitis C virus infection recurrence after liver transplantation....Pages 202-203
Hepatitis C virus Genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients....Pages 204-209
Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation....Pages 210-212
Expression of adhesion molecules and their ligands in liver allografts during cytomegalovirus (CMV) infection and acute rejection....Pages 213-215
Front Matter....Pages 217-217
Arrhythmogenic mortality in heart-transplant candidates....Pages 219-220
Cytomegalovirus infection accelerates obliterative bronchiolitis of rat tracheal allografts....Pages 221-222
Difference in cytokine production in acute and chronic rejection of rat lung allografts....Pages 223-225
Pravastatin prevents the progression of accelerated coronary artery disease after heart transplantation in a rabbit model....Pages 226-229
HLA-DR matching reduces rejection rate in heart transplantation....Pages 230-233
Phenotypic analysis of lymphocytes infiltrating human cardiac allografts during acute rejection and the development of graft vascular disease....Pages 234-236
Front Matter....Pages 217-217
Patterns in donor-specific mRNA and protein production of Th1 and Th2 cytokines by graft-infiltrating lymphocytes and PBMC after heart transplantation....Pages 237-240
Relationship between CMV and graft rejection after heart transplantation....Pages 241-242
Evoked epimyocardial electrogram for rejection diagnosis after heart transplantation....Pages 243-246
Valve reconstruction or replacement for long-term biopsy-induced tricuspid regurgitation following heart transplantation....Pages 247-248
Front Matter....Pages 249-249
Use of FK 506 in pancreas transplantation....Pages 251-257
Liposoluble antioxidants are not consumed in the pancreas after reperfusion in human simultaneous pancreas-kidney transplantation....Pages 258-260
Front Matter....Pages 261-261
Circumvention of natural killer cell and T-cell mediated allogeneic target killing with tacrolimus (FK506) in small bowel transplantation related graft-vs-host disease....Pages 263-268
Colon vs small bowel rejection after total bowel transplantation in a pig model....Pages 269-274
In vivo depletion of NKR-P1 positive cells in the recipient prior to small bowel transplantation enhances graft-versus-host disease (GvHD) in the rat....Pages 275-280
Changes in blood lymphocyte populations in experimental bowel allograft rejection....Pages 281-285
Microsurgical reconstruction of the lymphatic and nerve system in small bowel transplantation: the rat model, first results....Pages 286-289
Front Matter....Pages 291-291
Chronic rejection in lung allografts: immunohistological analysis of fibrogenesis....Pages 293-295
Clinical experience with retrograde lung preservation....Pages 296-298
Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation....Pages 299-302
Front Matter....Pages 303-303
Predicting patients’ exposure to cyclosporin....Pages 305-307
Mycophenolate mofetil in patients with acute renal failure: evidence of metabolite (MPAG) accumulation and removal by dialysis....Pages 308-310
UK multicentre study to assess the safety and tolerability of Neoral in stable renal transplant patients....Pages 311-313
Comparison of Sandimmun with a new cyclosporin derivative (IMM 125) in renal transplant patients with stable renal function....Pages 314-317
Induction of alloantigen-specific hyporesponsiveness in vitro by n-butyrate: antagonistic effect of cyclosporin A....Pages 318-322
Prolonged allograft survival by the inhibition of costimulatory CD2 signals but not by modulation of CD48 (CD2 ligand) in the rat....Pages 323-327
Front Matter....Pages 303-303
A short-term combination therapy with cyclosporine and rapamycin or leflunomide induces long-term heart allograft survival in a strongly immunogenic strain combination in rats....Pages 328-330
Effect of RS61443 in combination with leflunomide or FK506 on rat heart allograft survival....Pages 331-333
Front Matter....Pages 335-335
Rat MHC class I peptides are immunogenic....Pages 337-339
Correlation between the intensity of cytomegalovirus infection and the amount of perivasculitis in aortic allografts....Pages 340-344
Evidence that cyclosporin A prevents clinical cardiac allograft rejection by blocking both direct and indirect antigen presentation pathways....Pages 345-347
Liver sinusoidal lymphocytes: their immune functions....Pages 348-351
Determination of HLA-B7 T-cell epitopes....Pages 352-355
HLA class I A and B typing in the clinical laboratory using DNA-based techniques....Pages 356-363
Flow cytometric crossmatching in renal transplantation — outcome after five years....Pages 364-367
Allograft tolerance by intrathymic donor splenocyte transfer: an age-dependent, species-specific phenomenon?....Pages 368-371
Total lymphoid irradiation, without intrathymic injection of donor cells, induces indefinite acceptance of heart but not islet or skin allografts in rats....Pages 372-378
Induction of specific inhibition of alloreactivity in beagle dogs by intrathymic injection of donor splenocytes....Pages 379-381
Front Matter....Pages 383-383
Expression of human decay accelerating factor (hDAF) in transgenic pigs regulates complement activation during ex vivo liver perfusion — immunopathological findings....Pages 385-387
Long-duration xenogeneic extracorporeal pig liver perfusion with human blood....Pages 388-391
The function of transgenic human DAF-expressing porcine livers during hemoperfusion with human blood....Pages 392-396
Front Matter....Pages 397-397
Costs of drugs used after renal transplantation....Pages 399-402
Ethical aspects of using “marginal” kidneys for transplant....Pages 403-406
Front Matter....Pages 407-407
Donor heart quality control. Analysis of echocardiographic (EC) findings and patient outcome....Pages 409-413
Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria....Pages 414-417
The impact of donor age on graft outcome after liver transplantation....Pages 418-419
Front Matter....Pages 407-407
The anti-ischemic drugs defibrotide and oligotide analogously inhibit leukocyte-endothelial cell adhesion in vitro....Pages 420-424
Reduction in nonparenchymal cell injury and vascular endothelial dysfunction after cold preservation of the liver by gaseous oxygen....Pages 425-428
Influence of UW solution on in vitro platelet aggregability....Pages 429-431
Why is liver preservation performed at 4°C?....Pages 432-436
Na-K/2Cl transporter inhibition for reduction of postischemic kidney failure tested in autologous reperfusion....Pages 437-441
Minimal amounts of hyaluronidase in HTK or UW solution substantially improve the recovery of preserved hearts....Pages 442-446
Synergistic effects of nafamostat mesilate rinse and Kupffer cell blockade for rat liver preservation....Pages 447-451
Tissue hydration in kidneys during preservation: a relaxometric analysis of time-dependent differences between cortex and medulla....Pages 452-454
Changes in renal hemodynamics and physiology after normothermic ischemia in animals supplemented with eicosapentaenoic acid....Pages 455-459
Donor organ procurement in the North Italy Transplant program (NITp) in 1994: the beginning of a promising trend?....Pages 460-463
Regionalization of donor organ procurement: first experiences in southern Bavaria and results of a regional donor hospital survey....Pages 464-468
Marginal donors for patients on regular waiting lists for liver transplantation....Pages 469-471
Injury to hepatocytes and non-parenchymal cells during the preservation of human livers with UW or HTK solution: a determination of hepatocellular enzymes in the effluent perfusate for preoperative evaluation of the transplant quality....Pages 472-476
Pharmacokinetics of rinse solutions at 4° celsius....Pages 477-478
Assessment of oxygen radicals during kidney transplantation — effect of radical scavenger....Pages 479-482
Front Matter....Pages 483-483
Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson’s disease....Pages 485-491
Comparative analysis of immunological reconstitution induced by vascularized bone marrow versus bone marrow cell transplantation....Pages 492-496
Back Matter....Pages 499-499